Centessa Pharmaceuticals (CNTA) Competitors $21.90 -0.12 (-0.53%) As of 10:22 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNTA vs. RVMD, GRFS, RYTM, LEGN, ABVX, RNA, CYTK, AXSM, NUVL, and TGTXShould you be buying Centessa Pharmaceuticals stock or one of its competitors? The main competitors of Centessa Pharmaceuticals include Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Axsome Therapeutics (AXSM), Nuvalent (NUVL), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. Centessa Pharmaceuticals vs. Its Competitors Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Avidity Biosciences Cytokinetics Axsome Therapeutics Nuvalent TG Therapeutics Centessa Pharmaceuticals (NASDAQ:CNTA) and Revolution Medicines (NASDAQ:RVMD) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends. Which has higher earnings & valuation, CNTA or RVMD? Centessa Pharmaceuticals has higher revenue and earnings than Revolution Medicines. Centessa Pharmaceuticals is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentessa Pharmaceuticals$6.85M428.20-$235.76M-$1.79-12.24Revolution MedicinesN/AN/A-$600.09M-$4.50-10.25 Is CNTA or RVMD more profitable? Centessa Pharmaceuticals' return on equity of -40.39% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Centessa PharmaceuticalsN/A -40.39% -29.87% Revolution Medicines N/A -41.78%-35.63% Which has more risk and volatility, CNTA or RVMD? Centessa Pharmaceuticals has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Does the media favor CNTA or RVMD? In the previous week, Revolution Medicines had 33 more articles in the media than Centessa Pharmaceuticals. MarketBeat recorded 49 mentions for Revolution Medicines and 16 mentions for Centessa Pharmaceuticals. Revolution Medicines' average media sentiment score of 0.41 beat Centessa Pharmaceuticals' score of 0.15 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centessa Pharmaceuticals 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Revolution Medicines 15 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer CNTA or RVMD? Centessa Pharmaceuticals currently has a consensus price target of $32.44, indicating a potential upside of 48.12%. Revolution Medicines has a consensus price target of $73.67, indicating a potential upside of 59.75%. Given Revolution Medicines' higher possible upside, analysts plainly believe Revolution Medicines is more favorable than Centessa Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centessa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 3.07 Do insiders & institutionals believe in CNTA or RVMD? 82.0% of Centessa Pharmaceuticals shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 7.1% of Centessa Pharmaceuticals shares are held by insiders. Comparatively, 8.2% of Revolution Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryCentessa Pharmaceuticals and Revolution Medicines tied by winning 7 of the 14 factors compared between the two stocks. Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNTA vs. The Competition Export to ExcelMetricCentessa PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.94B$2.53B$5.72B$10.26BDividend YieldN/A57.22%5.72%4.60%P/E Ratio-12.2823.1875.1426.27Price / Sales428.20532.42513.55173.47Price / CashN/A27.5625.8129.90Price / Book7.185.3713.536.28Net Income-$235.76M$32.95M$3.28B$270.21M7 Day Performance5.06%-0.47%0.01%1.69%1 Month Performance21.35%4.09%4.45%5.84%1 Year Performance33.07%-2.48%76.84%25.21% Centessa Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNTACentessa Pharmaceuticals3.1436 of 5 stars$21.90-0.5%$32.44+48.1%+29.6%$2.94B$6.85M-12.28200Positive NewsInsider TradeGap UpRVMDRevolution Medicines4.1914 of 5 stars$41.06+1.4%$72.00+75.4%+5.7%$7.57B$11.58M-9.12250Insider TradeAnalyst RevisionGRFSGrifols3.9889 of 5 stars$10.11-0.2%$10.30+1.9%+4.0%$6.96B$7.81B8.6423,822Gap UpRYTMRhythm Pharmaceuticals3.3048 of 5 stars$99.77-2.3%$101.57+1.8%+93.5%$6.78B$130.13M-33.15140Positive NewsLEGNLegend Biotech3.1967 of 5 stars$34.62-4.0%$74.22+114.4%-32.7%$6.66B$627.24M-39.342,609Positive NewsABVXAbivax2.3983 of 5 stars$90.00+2.2%$92.33+2.6%+632.7%$6.65BN/A0.0061Analyst UpgradeShort Interest ↑Gap DownRNAAvidity Biosciences2.093 of 5 stars$48.05-4.6%$67.00+39.4%-3.6%$6.48B$10.73M-13.50190Analyst ForecastCYTKCytokinetics4.3746 of 5 stars$52.09-1.7%$75.38+44.7%-11.5%$6.34B$18.47M-10.21250Positive NewsInsider TradeAXSMAxsome Therapeutics4.8871 of 5 stars$129.29+3.3%$177.86+37.6%+24.7%$6.25B$385.69M-25.50380Positive NewsNUVLNuvalent3.1655 of 5 stars$79.83-1.3%$120.91+51.5%-9.2%$5.83BN/A-16.2940Positive NewsTGTXTG Therapeutics4.3012 of 5 stars$32.38+0.5%$46.25+42.8%+33.8%$5.11B$329M87.51290Positive News Related Companies and Tools Related Companies RVMD Alternatives GRFS Alternatives RYTM Alternatives LEGN Alternatives ABVX Alternatives RNA Alternatives CYTK Alternatives AXSM Alternatives NUVL Alternatives TGTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CNTA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTA Stock Alerts